Relay Therapeutics RLAY
NASDAQ RLAY
$19.04 +0.03 (+0.16%)
As of: Sep 4, 2026 · 3:59 PM EDT

Relay Therapeutics (RLAY) Prepaid Assets (2019 - 2026)

Relay Therapeutics (RLAY) posted quarterly Prepaid Assets of $4.6 million for Q1 2026, down 79.22% year-over-year from $22.0 million in Q1 2025, and down 74.35% quarter-over-quarter from $17.8 million in Q4 2025.

Analysis

Relay Therapeutics (RLAY) Prepaid Assets (2019 - 2026) Analysis & Trends

Relay Therapeutics (RLAY) has reported Prepaid Assets for 8 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets fell 79.22% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 79.22% YoY), while the FY2025 annual figure was $17.8 million, up 68.87% from the prior year.
  • Prepaid Assets declined to $4.6 million in Q1 2026 per RLAY's latest filing, from $17.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $22.0 million in Q1 2025 and bottomed at $3.3 million in Q4 2023.
  • Historically, Prepaid Assets has averaged $11.0 million across 5 years, with a median of $11.3 million in 2023.
  • Annual changes were most pronounced in 2024 — Prepaid Assets jumped 217.74% — and 2025, when it sank 80.01%.
  • Relay Therapeutics' Prepaid Assets stood at $12.1 million in 2022, then tumbled by 72.63% to $3.3 million in 2023, then surged by 217.74% to $10.5 million in 2024, then surged by 68.87% to $17.8 million in 2025, then plunged by 74.35% to $4.6 million in 2026.
  • Business Quant data shows RLAY's Prepaid Assets at $4.6 million in Q1 2026, $17.8 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Relay Therapeutics 3.87 Bn 3.87 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.74 Mn
Mar 31, 2026 11.84 Mn
Dec 31, 2025 17.79 Mn
Sep 30, 2025 23.84 Mn
Jun 30, 2025 16.04 Mn
Mar 31, 2025 21.95 Mn
Dec 31, 2024 17.35 Mn
Sep 30, 2024 18.73 Mn
Jun 30, 2024 10.12 Mn
Mar 31, 2024 13.19 Mn
Dec 31, 2023 16.70 Mn
Sep 30, 2023 17.29 Mn
Jun 30, 2023 9.31 Mn
Mar 31, 2023 11.27 Mn
Dec 31, 2022 12.11 Mn
Sep 30, 2022 16.81 Mn
Jun 30, 2022 12.75 Mn
Mar 31, 2022 12.66 Mn
Dec 31, 2021 11.47 Mn
Sep 30, 2021 17.70 Mn